Showing results (1461-1470 of 5,257) with videos related to
Sort By:
Pageof 526
Oncology|August 19, 2021
Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal AdenocarcinomaAnna Maria Nurmi, Harri Mustonen, Caj Haglund, et al.Oncology|August 23, 2021
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31Natalie F Berger, Brittney S Zimmerman, Serena Tharakan, et al.Oncology|November 24, 2004
Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patientsKyriaki Mystakidou, Charles Cleeland, Eleni Tsilika, et al.Oncology|November 24, 2004
Testicular lymphoma: organ-specific treatment did not improve outcomeAgustin Avilés, Natividad Neri, Judith Huerta-Guzmán, et al.Oncology|November 24, 2004
Clinical perspective on desmoplastic small round-cell tumorAlberto Gil, Alberto Gomez Portilla, Erwin A Brun, et al.Oncology|November 24, 2004
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II studyD Mavroudis, N Malamos, A Polyzos, et al.Oncology|November 24, 2004
Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: a phase I/II studyL Cals, P Nouyrigat, B Valenza, et al.Oncology|November 24, 2004
Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapyF Blasco, S Peñuelas, M Cascalló, et al.Oncology|November 24, 2004
Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cellsMasami Niiya, Kenji Niiya, Misako Shibakura, et al.Oncology|June 26, 2004
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology groupRobert C Shepard, Donna E Levy, Jordan D Berlin, et al.Pageof 526